Integrating pharmacogenomics into pharmacy practice via medication therapy management

Journal of the American Pharmacists Association

Volumn 51, Issue 6, 2011, Pages

  Owen, James A ^a  

^a AMERICAN PHARMACISTS ASSOCIATION   (United States)

Author keywords

Health information technology; Medication therapy management; Personalized health care; Pharmacogenomics; Pharmacy practice

Indexed keywords

CLINICAL PHARMACY; CLINICAL PRACTICE; DECISION SUPPORT SYSTEM; DRUG LABELING; DRUG METABOLISM; DRUG RESPONSE; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; ELECTRONIC MEDICAL RECORD; ELECTRONIC PRESCRIBING; FOOD AND DRUG ADMINISTRATION; GENETIC VARIABILITY; HEALTH CARE DELIVERY; HEALTH CARE INDUSTRY; HEALTH CARE PERSONNEL; HUMAN; MEDICAID; MEDICAL INFORMATICS; MEDICAL INFORMATION; MEDICATION THERAPY MANAGEMENT; PATIENT CARE; PATIENT SAFETY; PERSONALIZED MEDICINE; PHARMACIST; PHARMACOGENOMICS; POSTMARKETING SURVEILLANCE; REVIEW; ARTICLE; GOVERNMENT; METHODOLOGY; ORGANIZATION AND MANAGEMENT; PHARMACOGENETICS; PHARMACY; PROFESSIONAL STANDARD; STANDARD; UNITED STATES;

HUMANS; INDIVIDUALIZED MEDICINE; MEDICAL INFORMATICS; MEDICATION THERAPY MANAGEMENT; PATIENT CARE; PHARMACEUTICAL SERVICES; PHARMACISTS; PHARMACOGENETICS; PROFESSIONAL ROLE; UNITED STATES; UNITED STATES DEPT. OF HEALTH AND HUMAN SERVICES;

EID: 84857462480     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/JAPhA.2011.11543     Document Type: Article

References (22)

1. Department of Health & Human Services. HS Secretary Leavitt announces steps toward a future of "personalized health care. Accessed at www.hhs.gov/news/press/2007pres/20070323a.html, August 27, 2011.
2. Food and Drug Administration. FDA's Sentinel Initiative. Accessed at www.fda.gov/Safety/FDAsSentinelInitiative/ucm2007250.htm, August 27, 2011.
3. Hamburg MA. Remarks. Proceedings of Personalized Medicine: Planning for the Future, Washington, DC, October 26-27, 2009. Washington, DC: American Association for the Advancement of Science; 2009.
4. Hamburg MA. Remarks. Proceedings of the Personalized Medicine Coalition's Sixth Annual Keynote Luncheon, February 25, 2010. Washington, DC: Personalized Medicine Coalition; 2010.
5. Food and Drug Administration. FDA Drug Safety Communication: reduced effectiveness of Plavix (clopidogrel) in patients who are poor metabolizers of the drug. Accessed at www.fda.gov/Drugs/DrugSafety/ PostmarketDrugSafetyInformationforPatientsand-Providers/ucm203888.htm, August 27, 2011.
6. Lesko LJ. The critical path of warfarin dosing: finding an optimal dosing strategy using pharmacogenetics. Clin Pharmacol Ther. 2008;84:301-3.
7. Food and Drug Administration. Information for healthcare professionals: use of codeine products in nursing mothers. Accessed at www.fda.gov/Drugs/ DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm124889.htm, August 27, 2011.
8. Food and Drug Administration. Cetuximab (Erbitux) and panitumumab (Vectibix) class labeling changes. Accessed at www.fda.gov/AboutFDA/ CentersOffices/CDER/ucm172905.htm, August 27, 2011.
9. Bluml BM. Definition of medication therapy management: development of a profession wide consensus. J Am Pharm Assoc. 2005;45:566-72.
10. American Pharmacists Association, National Association of Chain Drug Stores Foundation. Medication therapy management in pharmacy practice: core elements of an MTM service model (version 2.0) J Am Pharm Assoc. 2008; 48:341-53.
11. Posey LM. Narrowing the gap between science, practice. Pharmacy Today. 2008;14(3):29.
12. National Institutes of Medicine. Preventing medication errors: quality chasm series. Washington, DC: National Academies Press; 2006.
13. Surescripts. The national progress report on e-prescribing and interoperable healthcare: 2010. Accessed at www.surescripts.com/about-e- prescribing/progress-reports/national-progress-reports. aspx, August 27, 2011.
14. PL 111-5, §13, Division A, Health Information Technology, and §4, Division B, Medicare and Medicaid Health Information Technology.
15. PL 110-275, §132.
16. Pharmacy e-Health Information Technology Collaborative. Homepage. Accessed at www.pharmacyhit.org, August 27, 2011.
17. Medco Health Solutions. 2009 Medco drug trend report. Vol. 11, p. 84. Accessed at http://medco.mediaroom.com/index.php?s=17885&cat=1561, August 27, 2011.
18. Medco Health Solutions. 2009 Medco drug trend report. Vol. 11, p. 8. Accessed at http://medco.mediaroom.com/index.php?s=17885&cat=1561, August 27, 2011.
19. Chun-Ju H, Beatty PC, Hing ES, et al. NCHS health e-stat: electronic medical record/electronic health record use by office-based physicians: United States, 2008 and preliminary 2009. Accessed at www.cdc.gov/nchs/data/hestat/emr- ehr/emr-ehr.htm#ref1, August 27, 2011.
20. Markman M. Tamoxifen metabolism and CYP2D6. Accessed at http://emedicine.medscape.com/article/1762071-overview, August 27, 2011.
21. Saneto RP, Lee IC, Koenig MK, et al. POLG DNA testing as an emerging standard of care before instituting valproic acid therapy for pediatric seizure disorders. Seizure. 2010;19(3):140-6.
22. Spear BB, Heath-Chiozzi M, Huff J. Clinical applications of pharmacogenetics. Trends Mol Med. 2001;7:201-4.